RENATA: 2QFY23 Earnings Update

  • Post category:

·         Revenue decreased by 0.7% YoY. Pharmaceutical segment which constituted 85.9% of the revenue, posted 6.7% negative growth. Revenue from contract manufacturing increased by ~80.0%. ·         Cost of sales increased significantly by…

Continue ReadingRENATA: 2QFY23 Earnings Update